Ethyl (rac)-7-(4-cyanophenyl)-5-methyl-2-[(trifluoroacetyl)amino]-4,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate | 1234620-69-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三唑并嘧啶类
• 英文名称: Ethyl (rac)-7-(4-cyanophenyl)-5-methyl-2-[(trifluoroacetyl)amino]-4,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate
• 英文别名: Ethyl 7-(4-cyanophenyl)-5-methyl-2-[(trifluoroacetyl)amino]-4,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate；ethyl 7-(4-cyanophenyl)-5-methyl-2-[(2,2,2-trifluoroacetyl)amino]-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate
• CAS: 1234620-69-9
• 化学式: C₁₈H₁₅F₃N₆O₃
• 分子量: 420.351
• InChiKey: UKWDXNMFYFZQNT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  30
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  122
• 氢给体数：
  2
• 氢受体数：
  10

反应信息

• 作为反应物：
  描述：

  Ethyl (rac)-7-(4-cyanophenyl)-5-methyl-2-[(trifluoroacetyl)amino]-4,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate 、 3-(三氟甲基)苯硼酸 在 吡啶 、 copper diacetate 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 36.0h， 以17%的产率得到Ethyl (rac)-7-(4-cyanophenyl)-5-methyl-2-[(trifluoroacetyl)amino]-4-[3-(trifluoromethyl)phenyl]-4,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate
  参考文献：
  名称：

  TRIAZOLO AND TETRAZOLO PYRIMIDINE DERIVATIVES AS HNE INHIBITORS FOR TREATING COPD

  摘要：

  本发明涉及新颖的杂环融合二芳基二氢嘧啶衍生物，涉及它们的制备方法，涉及它们单独或与其他物质结合用于治疗和/或预防疾病，以及涉及它们用于制备用于治疗和/或预防疾病的药物，特别是用于治疗和/或预防肺部和心血管系统疾病的药物。

  公开号：

  US20120004203A1
• 作为产物：
  描述：

  ethyl (E/Z)-2-(4-cyanobenzylidene)-3-oxobutanoate 在 吡啶 、 碳酸氢钠 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 13.0h， 生成 Ethyl (rac)-7-(4-cyanophenyl)-5-methyl-2-[(trifluoroacetyl)amino]-4,7-dihydro[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate
  参考文献：
  名称：

  TRIAZOLO AND TETRAZOLO PYRIMIDINE DERIVATIVES AS HNE INHIBITORS FOR TREATING COPD

  摘要：

  本发明涉及新颖的杂环融合二芳基二氢嘧啶衍生物，涉及它们的制备方法，涉及它们单独或与其他物质结合用于治疗和/或预防疾病，以及涉及它们用于制备用于治疗和/或预防疾病的药物，特别是用于治疗和/或预防肺部和心血管系统疾病的药物。

  公开号：

  US20120004203A1

文献信息

• NOVEL INHIBITORS
  申请人：Heiser Ulrich

  公开号：US20110092501A1

  公开（公告）日：2011-04-21

  The invention relates to novel pyrrolidine derivatives of formula (I): wherein R 1 , R 2 and R 3 are as defined herein, as inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5). QC catalyzes the intramolecular cyclization of N-terminal glutamine residues into pyroglutamic acid (5-oxo-prolyl, pGlu*) under liberation of ammonia and the intramolecular cyclization of N-terminal glutamate residues into pyroglutamic acid under liberation of water.

  本发明涉及新颖的吡咯烷衍生物，其具有如下公式(I)：其中R1、R2和R3如本文所述定义，作为谷氨酰胺环化酶（QC，EC 2.3.2.5）的抑制剂。谷氨酰胺环化酶催化N末端谷氨酰胺残基形成焦谷氨酸（5-氧代脯氨酸，pGlu*）的分子内环化，并释放氨，以及催化N末端谷氨酸残基形成焦谷氨酸的分子内环化，并释放水。
• INDOLINE DERIVATIVES
  申请人：Sugimoto Hachiro

  公开号：US20110294850A1

  公开（公告）日：2011-12-01

  The present invention provides a novel indoline derivative or a pharmacologically acceptable salt thereof or a solvate of the derivative or a salt thereof represented by the following formula (1) that has an excellent butyrylcholinesterase inhibitory activity. In the formula, R 1 represents an alkyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an arylalkyl group, a heteroarylalkyl group, a cycloalkylalkyl group, a heterocycloalkylalkyl group, a dihydrofurylalkyl group, an alkenyl group, a tetrahydronaphthyl group, or an indanyl group; R 2 represents a hydrogen atom, an alkyl group, an arylalkyl group, a cycloalkylalkyl group, a heteroarylalkyl group, a heterocycloalkylalkyl group, an aryl group, or an acyl group; R 3 each independently represents a hydrogen atom, an alkyl group, or a dialkylaminocarbonyl group; R 4 each independently represents a hydrogen atom or an alkyl group; and R 5 represents a hydrogen atom or an alkyl group. Each functional group may have a substituent.

  本发明提供了一种新的吲哚啉衍生物，或者其药理学上可接受的盐，或者所述衍生物的溶剂或其盐的溶剂，其由以下式（1）所代表，具有优异的丁酰胆碱酯酶抑制活性。在该式中，R1代表烷基，环烷基，杂环烷基，芳基，杂芳基，芳基烷基，杂芳基烷基，环烷基烷基，杂环烷基烷基，二氢呋喃基烷基，烯基，四氢萘基或吲哚基；R2代表氢原子，烷基，芳基烷基，环烷基烷基，杂芳基烷基，杂环烷基烷基，芳基或酰基；R3各自独立地代表氢原子，烷基或二烷基氨基甲酰基；R4各自独立地代表氢原子或烷基；R5代表氢原子或烷基。每个功能基团可能有取代基。
• [EN] 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS<br/>[FR] COMPOSES 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE POUR LE TRAITEMENT DE LA TUBERCULOSE
  申请人：OTSUKA PHARMA CO LTD

  公开号：WO2005042542A1

  公开（公告）日：2005-05-12

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1)in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and -(CH2)nR2 may form a spiro ring represented by the formula (30) below, together with the adjacent carbon atom (in the formula below, RRR represents a piperidyl group which may have substituents on the piperidine ring), (30)and R2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria.

  本发明提供了一种由以下一般式表示的2,3-二氢-6-硝基咪唑[2,1-b]噁唑化合物：(1)在上述式(1)中，R1代表氢原子或C1-C6烷基，n代表0至6的整数，R1和-(CH2)nR2可以与下面的式(30)一起形成一个螺环，与相邻的碳原子一起（在下面的式中，RRR代表可能在哌啶环上具有取代基的哌啶基），(30)和R2代表苯并噻唑氧基、喹啉氧基、吡啶氧基或类似物。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型耐酸细菌具有出色的杀菌作用。
• PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST
  申请人：Kai Hidetomo

  公开号：US20110105703A1

  公开（公告）日：2011-05-05

  The invention relates to a novel iron complex bearing a cyclic amine as ligand; and a process for the production of polymers by polymerizing a radical-polymerizable monomer in the presence of the iron complex and a radical generator. The invention aims at providing a process by which a polymer having a chemically convertible functional group at the end can be produced from a radical-polymerizable monomer and which permits the production of a block copolymer and a process for recovering, after polymerization, an iron complex into a solvent at a high recovery ratio. The aim can be solved by providing a novel iron complex, a process for producing a polymer in the presence of a radical polymerization initiator by using the iron complex as the polymerization catalyst, a process for the production of a block copolymer which is subsequent to the polymerization for producing the above polymer, and a process for recovering the iron complex easily and simply. The invention provides an iron complex useful in producing a polymer by polymerizing a radical-polymerizable monomer; and a process for the production of polymers with the iron catalyst.

  该发明涉及一种具有环胺作为配体的新型铁配合物；以及通过在铁配合物和自由基发生剂的存在下聚合自由基可聚合单体来生产聚合物的方法。该发明旨在提供一种通过在自由基可聚合单体中生产具有化学可转化官能团末端的聚合物的方法，并且允许生产嵌段共聚物以及在聚合后将铁配合物以高回收率回收到溶剂中的方法。该目的可以通过提供一种新型铁配合物、在自由基聚合引发剂的存在下使用铁配合物作为聚合催化剂生产聚合物的方法、在上述聚合物生产后用于生产嵌段共聚物的方法以及轻松简便地回收铁配合物的方法来实现。该发明提供了一种有用的铁配合物，用于通过聚合自由基可聚合单体来生产聚合物；以及使用铁催化剂生产聚合物的方法。
• 7a-alkoxy-4H-pyrano [3,2-d] -oxazol-2 (3H) -one and process for producing the same
  申请人：——

  公开号：US20020072612A1

  公开（公告）日：2002-06-13

  The present invention provides a novel 7a-alkoxy-4H-pyrano-[3,2-d]-oxazol-2(3H)-one represented by the formula (I): 1 wherein R 1 and R 2 each represent a hydrogen atom, an alkyl group, an alkenyl group, an aryl group or an aralkyl group; R 3 represents an alkyl group, a cycloalkyl group, an alkenyl group, an aryl group or an aralkyl group, provided that a 2-alkenyl group is excluded from the alkenyl group of R 3 ; and R 4 represents an alkyl group, an aryl group, an alkoxycarbonyl group or a cyano group, and a process for producing the same which comprises reacting 5-alkoxy-2(3H)-oxazolone with an &agr;,&bgr;-unsaturated ketone in the presence of a Lewis acid in a solvent.

  本发明提供了一种新型的7a-烷氧基-4H-吡喃-[3,2-d]-噁唑-2(3H)-酮，其化学式表示为(I)：其中R1和R2分别代表氢原子、烷基、烯基、芳基或芳基烷基；R3代表烷基、环烷基、烯基、芳基或芳基烷基，但要求R3的烯基中排除2-烯基；R4代表烷基、芳基、烷氧羰基或氰基；以及一种制备该化合物的方法，包括在溶剂存在下，将5-烷氧基-2(3H)-噁唑酮与α,β-不饱和酮在Lewis酸存在下反应。